Financials

  • Market Capitalization 266.1364 M
  • Employee 213
  • Founded 1996
  • CEO N/A
  • Website www.simulations-plus.com
  • Headquarter North Carolina, United States
  • FIGI BBG000BS2ZD1
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.47
Relación precio/flujo de caja
3.65
Dividendos por acción
Rendimiento por dividendo, %

Simulations Plus Inc

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

Noticias